Moreover, IL-10 has pro-tumor activity in TME, and IL-10 facilitated Tregs and M2-like macrophages development [129], as well as counteracting CD4+ T cells, cytotoxic CD8+ T cells and NKs tumoricidal function [34]. The gene discussed is CD8A; the disease is neoplasm.